Aimed Alliance Comments on CMS’s Essential Health Benefits RFI
On July 14, 2026, Aimed Alliance submitted a comment to the Department of Health and…
Browsing: State
Aimed Alliance Urges Colorado PDAB Not to Establish a UPL for Cosentyx
On June 24, Aimed Alliance sent a letter to the Colorado Prescription Drug Affordability Board…
Aimed Alliance Pushes for Expanding Specialized Access for Adults with Rare Diseases in Massachusetts
On June 15, 2026, Aimed Alliance, alongside KIF1A.ORG, sent a letter to the Massachusetts Division…
Aimed Alliance Comments on Proposed CMS Rule Regarding Electronic Prior Authorization
On June 15, 2026, Aimed Alliance sent a letter to the Centers for Medicare &…
Aimed Alliance Releases New Report on the Evolving Landscape of State AI Policy
On June 16, 2026, Aimed Alliance released its latest publication, Guardrails for Care: AI and…
FDA Warns Manufacturers Remain Liable for AI-Generated Work
The Food and Drug Administration’s (FDA) integration of artificial intelligence (AI) into drug development and…
OIG Assessment of Vertical Integration Underscores Transparency Gaps
A recent Office of Inspector General (OIG) report investigating the impact of vertical integration in…
Governor Spanberger Vetoes PDAB Bills, Citing Cost and Ineffectiveness
On May 19, Governor Spanberger vetoed H.B.483/S.B.271, which would have established a Prescription Drug Affordability…
Pennsylvania Sues Character.ai Over AI Posing as Licensed Medical Professionals
On May 1, 2026, Pennsylvania filed a lawsuit against Character.ai, a generative artificial intelligence (AI)…
FTC and CVS Caremark Pursue Settlement
On March 23, 2026, the FTC and CVS Caremark jointly moved to withdraw from the…